As cholesterol is metabolically required by human cells, growth of ALK + ALCL cells is sensitive to cholesterol-depleting therapy or targeting the low-density lipoprotein receptor (LDLR) [27]. The gene discussed is LDLR; the disease is anaplastic large cell lymphoma.